Shortages of medicines: A complex global challenge

Bulletin of the World Health Organization

Volumn 90, Issue 3, 2012, Pages

  Gray, Andy ^a   Manasse, Henri R ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGALSIDASE BETA; ANESTHETIC AGENT; ELECTROLYTE; GENERIC DRUG; IMIGLUCERASE; INFLUENZA VACCINE; PROPOFOL; RADIOPHARMACEUTICAL AGENT; STREPTOMYCIN;

DRUG INDUSTRY; DRUG MANUFACTURE; DRUG QUALITY; EDITORIAL; GEOGRAPHIC DISTRIBUTION; GOVERNMENT REGULATION; HEALTH CARE CONCEPTS; MEDICINE SHORTAGE; STANDARDIZATION;

HEALTH POLICY; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PRESCRIPTION DRUGS; UNITED STATES; WORLD HEALTH;

EID: 84857848388     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.11.101303     Document Type: Editorial

References (18)

1. Gatesman ML, Smith TJ. The shortage of essential chemotherapy drugs in the United States. N Engl J Med 2011;365:1653-5. doi:10.1056/ NEJMp1109772 PMID:22040130
2. Chabner BA. Drug shortages-a critical challenge for the generic-drug market. N Engl J Med 2011;365:2147-9. doi:10.1056/NEJMp1112633 PMID:22040167
3. Jensen V, Rappaport BA. The reality of drug shortages-the case of the injectable agent propofol. N Engl J Med 2010;363:806-7. doi:10.1056/ NEJMp1005849 PMID:20554977
4. Mirtallo JM. The drug shortage crisis. J Parenter Enteral Nutr 2011;35:433. doi:10.1177/0148607111412051 PMID:21700962
5. Steinbrook R. Drug shortages and public health. N Engl J Med 2009;361:1525-7. doi:10.1056/NEJMp0906922 PMID:19828529
6. Quilty S, Harris LM, Kewley J, Jones A, Pearce R, James R et al. A Pandora's box: sustainable pharmaceutical supply. Med J Aust 2011;195:510-1. doi:10.5694/mja11.11150 PMID:22060075
7. Eggertson L. Drug shortage registry under discussion. CMAJ 2011;183:E637-E638. doi:10.1503/cmaj.109-3904 PMID:21624912
8. Beerten E, Bonheure F. Autour du monde - des indisponsibilités de médicaments. Annales Pharmaceutiques Belges 2011; Nov 15: 11-14.
9. Shortage of streptomycin: time for a change of approach? Lancet 2010;376:1712. doi:10.1016/S0140-6736(10)62116-2 PMID:21093635
10. Charatan F. Prescription drug shortages plague US. BMJ 2001;322:130. PMID:11159566
11. Drug shortages: a closer look at products, suppliers and volume volatility. Danbury CT: IMS Institute for Healthcare Informatics; 2011. Available from: http://www.imshealth.com/vgn-ext-templating/v/index.jsp?vgnextoid=4737087078483310VgnVCM100000ed152ca2RCRD [accessed 9 December 2011].
12. Waning B, Diedrichsen E, Jambert E, Bärnighausen T, Li Y, Pouw M et al. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. BMC Pediatr 2010;10:74. doi:10.1186/1471-2431-10-74 PMID:20950492
13. A review of FDA's approach to medical product shortages. Silver Spring: United States Food and Drug Administration; 2011. Available from: http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/ucm277755.pdf [accessed 9 December 2011].
14. Haninger K, Jessup A, Koehler K. Economic analysis of the causes of drug shortages (policy brief). Washington: United States Department of Health and Human Services; 2011. Available from: http://www.aspe.hhs.gov/sp/reports/2011/drugshortages/ib.shtml [accessed 9 December 2011].
15. FIP calls attention to medicines shortages [Internet]. The Hague: International Pharmaceutical Federation; 2011. Available from: http://www.fp.org/www/index.php?page=latest_news&news=newsitem&newsitem=118 [accessed 15 February 2012].
16. Preserving Access to Life-Saving Medications Act. HR2245. Washington: US Congress; 2011. Available from: http://www.ashp.org/DocLibrary/Advocacy/GAD/DeGetteRooney-bill-Summary.aspx [accessed 15 February 2012].
17. Preserving Access to Life-Saving Medications Act. S 296. Washington: US Congress; 2011. Available from: http://www.govtrack.us/congress/bill.xpd?bill=s112-296 [accessed 15 February 2012].
18. Gottlieb S. The causes of drug shortages and proposals for repairing these markets (Statement before the Committee on Oversight and Government Reform Subcommittee on Healthcare on 30 November 2011). Washington: American Enterprise Institute; 2011. Available from: http://www.aei.org/fles/2011/11/30/-the-causes-of-drug-shortages-and-proposals-for-repairing-these-markets_093714634757.pdf [accessed 9 December 2011].